← Back to patent-cliff list
Ciprofol
Tier C — Watch / tradeCiprofol
-
Originator
2020
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：GABAAR
Brand：CYPSEDO
Indications (approved)：Anaesthesia, Sedation
Regional status
US
Approved
2026-05-29
EU
-
China
Approved
2020-12-11
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ciprofol?
Approved indications include: Anaesthesia, Sedation.
When does the Ciprofol patent expire?
No public expiry year is available for Ciprofol yet; this page updates once verified.
How do I get a quote for Ciprofol intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27